|
| ID |
DDInter1598 |
| Drug Type |
small molecule |
| Molecular Formula |
C28H28F2N6O3 |
| Molecular Weight |
534.567
|
| Description |
Rimegepant is an oral CGRP receptor antagonist used for the acute treatment of migraines with or without aura in adults.
|
| ATC Classification |
- |
| IUPAC Name |
(5S,6S,9R)-5-Amino-6-(2,3-Difluorophenyl)-5H,6H,7H,8H,9H-Cyclohepta[B]Pyridin-9-Yl 4-{2-Oxo-1H,2H,3H-Imidazo[4,5-B]Pyridin-1-Yl} |
| InChI |
Inchi=1S/C28H28F2N6O3/C29-20-6-1-4-17(23(20)30)18-8-9-22(25-19(24(18)31)5-2-12-32-25)39-28(38)35-14-10-16(11-15-35)36-21-7-3-13-33-26(21)34-27(36)37/H1-7,12-13,16,18,22,24H,8-11,14-15,31H2,(H,33,34,37)/T18-,22+,24-/M0/S1 |
| InChI Key |
KRNAOFGYEFKHPB-ANJVHQHFSA-N |
| Canonical SMILES |
N[C@H]1[C@@H](CC[C@@H](OC(=O)N2CCC(CC2)N2C(=O)NC3=NC=CC=C23)C2=C1C=CC=N2)C1=C(F)C(F)=CC=C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|